Healios KK
TSE:4593
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Healios KK
TSE:4593
|
JP |
|
HAL Trust
AEX:HAL
|
NL |
|
Schindler Holding AG
SIX:SCHP
|
CH |
|
Grupa Azoty SA
F:5PL
|
PL |
|
S
|
Siemens AG
DUS:SIE
|
DE |
|
Suncor Energy Inc (Canada)
TSX:SU
|
CA |
|
M
|
Minebea Mitsumi Inc
DUS:MEA
|
JP |
|
S
|
Silvercorp Metals Inc
DUS:S9Y
|
CA |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
Nippon Care Supply Co Ltd
OTC:NYLPF
|
JP |
|
Almonty Industries Inc
NASDAQ:ALM
|
CA |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
Vcplus Ltd
SGX:43E
|
MY |
|
S
|
St Joe Co
F:JOE
|
US |
|
Andhra Petrochemicals Ltd
BSE:500012
|
IN |
|
M
|
Monroe Federal Bancorp Inc
OTC:MFBI
|
US |
|
Macquarie Group Ltd
F:4M42
|
AU |
|
Sriwahana Adityakarta Tbk PT
IDX:SWAT
|
ID |
|
C
|
Cheniere Energy Inc
XMUN:CHQ1
|
US |
|
M
|
Marcus Corp
F:3L1
|
US |
|
G
|
Gunkul Engineering PCL
SET:GUNKUL
|
TH |
Intrinsic Value
Is Healios KK undervalued or overvalued?
See the intrinsic value estimate for Healios KK and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Healios KK Does
Healios KK is a Japanese biotechnology company that develops regenerative medicine and cell therapy products. Its core work is to turn living cells into treatments for serious conditions such as stroke and acute respiratory failure, then move those therapies through testing, approval work, and partnering. It is not a traditional drugmaker with a wide catalog of medicines; it is closer to a specialist developer of advanced therapies.
- Headquarters
- Japan JP
- Employees
- 75
- IPO date
- Jun 16, 2015
Revenue & Expenses Breakdown
Healios KK
Earnings Waterfall
Healios KK
The intrinsic value for Healios KK (4593) under the Base Case is hidden JPY.
Compared with the current market price of 273 JPY, the stock appears hidden.